Zhengzhou University

This study is testing a combination of four different treatments for a rare type of brain cancer called primary central nervous system lymphoma. The treatment includes a personalized immune cell therapy (CAR-T), a stem cell transplant, and two other drugs. The goal is to see if t…

This study is testing a combination of three drugs—zanubrutinib, rituximab, and lenalidomide—as the first treatment for adults with advanced marginal zone lymphoma, a type of blood cancer. Researchers want to see if this combination helps patients live longer and is safe, compare…

This study is testing a new combination of four targeted drugs for adults with mantle cell lymphoma, a type of blood cancer, that has come back or stopped responding to a common type of medication called a BTK inhibitor. The goal is to see if this new drug mix can better control …